This filing is routine and carries no directional signal. Monitor for any discretionary insider selling patterns in future filings, but no immediate action required.
TVTX drugs
TVTX drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 6 $44.76entry
- T+1 · 6mo ago −4.69%α −4.36% · $42.66
- T+5 · 6mo ago −4.29%α −5.42% · $42.84
- T+20 · 6mo ago +0.98%α −1.80% · $45.20
- T+60 · 4mo ago +24.87%α +22.80% · $55.89
Price Chart
How similar events traded
Executive Summary
Elizabeth E. Reed, an officer of Travere Therapeutics, filed a Form 144 to sell 2,174 shares for approximately $101,417 to satisfy tax withholding obligations from vested performance restricted stock units. This is a mandatory, non-discretionary sale and does not reflect insider sentiment.
Key Facts
- Filer: Elizabeth E. Reed, officer (likely General Counsel)
- Shares to sell: 2,174
- Approximate value: $101,417
- Sale reason: Mandatory sell-to-cover for tax withholding on vesting of performance RSUs
- Transaction is not discretionary
Financial Impact
Negligible relative to company's $4.1B market cap
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001193125-26-207083 |
| Document: 0001193125-26-207083-index.html | 0001193125-26-207083 |
| Document: 0001193125-26-207083.txt | 0001193125-26-207083 |
Track record
21 reports on TVTX
8 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +56.24% at T+60 after the Jun 2, 2026 report. 10 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $50.30 Now $49.70 −1.19% settles Nov 23
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $48.87 to $51.56 Now $49.70 +1.70% ▲ +5.50% +2.21% vs SPY
- Nov 3, 202613d ago Institutional Cluster Bullish 4/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
- Nov 2, 202614d ago 8-K Bullish 6/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
- Sep 17, 20268w ago Insider Cluster Bearish 4/10 Entry $62.76 to $59.44 Now $49.70 +20.81% ▲ +5.29% +6.56% vs SPY
- Jul 9, 202618w ago 8-K Neutral 2/10 Entry $56.59 to $55.28 Now $49.70 −12.18% ▼ −2.31% −1.75% vs SPY
- Jun 16, 202621w ago Insider Cluster Neutral 2/10 Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
- Jun 16, 202621w ago 8-K Neutral 2/10 Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
- Jun 12, 202622w ago 144 Neutral 2/10 Entry $52.04 to $55.15 Now $49.70 −4.50% ▲ +5.98% +5.30% vs SPY
- Jun 2, 202623w ago 8-K Bullish 6/10 Entry $42.96 to $48.57 Now $49.70 +15.69% ▲ +13.06% +16.02% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers